Optimal Intervention to Full Viral Suppression: Text Me, Alexis! - Trial NCT06408350
Access comprehensive clinical trial information for NCT06408350 through Pure Global AI's free database. This phase not specified trial is sponsored by Friends Research Institute, Inc. and is currently Recruiting. The study focuses on HIV. Target enrollment is 195 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Friends Research Institute, Inc.
Timeline & Enrollment
N/A
Apr 11, 2024
Jun 30, 2028
Primary Outcome
Rate of HIV Viral Load Suppression,Relative Cost Effectiveness
Summary
Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal
 and most cost-effective intervention for advancing trans women living with HIV to full viral
 suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone,
 SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will
 receive unlimited navigation sessions over 3 months. Participants in the SMS alone and
 PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270
 unique scripted messages.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06408350
Non-Device Trial